Unregistered Sales of Equity Securities and Use of Proceeds.
−Removed: The following table summarizes common stock repurchases made during the first quarter of 2024 (shares in millions):
+Added: The following table summarizes common stock repurchases made during the second quarter of 2024 (shares in millions):
Issuer Purchases of Equity Securities
7 unchanged sentences
the Plans or Programs(a)
−Removed: January 1 — 31
−Removed: February 1 — 29 (b)
+Added: April 1 — 30 (b)
+Added: 1,238 million
+Added: 1,238 million
+Added: 1,238 million
(a) In the table above and footnotes below, the average price paid per share, total repurchase costs and approximate maximum dollar value of shares that may yet be purchased under the plans or programs exclude the 1% excise tax.
−Removed: (b) In October 2023, we executed an accelerated share repurchase (“ASR”) agreement to repurchase $300 million of our common stock.
−Removed: At the beginning of the repurchase period, we delivered $300 million in cash and initially received 1.5 million shares based on a stock price of $161.38.
−Removed: The ASR agreement completed in February 2024, at which time we received 0.2 million additional shares based on a final weighted average price of $175.29.
−Removed: In February 2024, we entered into an accelerated share repurchase (“ASR”) agreement to repurchase $250 million of our common stock.
−Removed: At the beginning of the repurchase period, we delivered $250 million cash and initially received 1.0 million shares based on a stock price of $199.16.
−Removed: The ASR agreement completed in April 2024, and we received 0.2 million additional shares based on a final weighted average price of $206.23.
−Removed: The average price per share reported in the table reflects the weighted average price of (i) the final share delivery from the October 2023 ASR, which was made in February 2024, and (ii) the initial share delivery of the February 2024 ASR.
−Removed: (c) As of March 31, 2024, the Company has authorization for $1.25 billion of future share repurchases.
+Added: (b) We repurchased 0.2 million shares of our common stock through a February 2024 ASR agreement that completed in April 2024, based on a final weighted average price of $206.23.
+Added: Additionally, we repurchased 0.1 million shares in open market transactions in compliance with Rule 10b5-1 and Rule 10b-18 of the Exchange Act for $12 million, inclusive of per-share commissions, at a weighted average price of $209.20.
+Added: See Note 11 to the Condensed Consolidated Financial Statements for additional information.
+Added: (c) As of June 30, 2024, the Company has authorization for $1,238 million of future share repurchases.
+Added: As a result of the planned Stericycle acquisition, the Company previously announced that it has temporarily suspended share repurchases.
The amount of future share repurchases executed under our Board of Directors’ authorization is determined in management’s discretion, based on various factors, including our net earnings, financial condition and cash required for future business plans, growth and acquisitions.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.